Clinical Trials · NCT02278185
Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- University of Colorado, Denver
- Enrollment
- 19
- Start date
- Nov 2015
- Locations
- 2 sites, United States
- Primary endpoint
- Metabolic Syndrome Incidence, Summarized by the Number of Patients With at Least 3 of the 5 Pre-specified Criteria